Home > Financial Ratios > JENBURKT PHARMACEUTICALS

JENBURKT PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for JENBURKT PHARMACEUTICALS
Please provide your vote to see the results

JENBURKT PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 9.005.966.836.735.38

What is the latest EV/Core EBITDA ratio of JENBURKT PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of JENBURKT PHARMACEUTICALS is 9.00 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar20259.00
Mar20245.96
Mar20236.83
Mar20226.73
Mar20215.38

How is EV/Core EBITDA of JENBURKT PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 9
51.01
Mar2024 5.96
-12.74
Mar2023 6.83
1.49
Mar2022 6.73
25.09
Mar2021 5.38 -

Other Financial Ratios of JENBURKT PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of JENBURKT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS ₹451.3 Cr -2.5% 1.2% 0.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,937.0 Cr 1.2% -7% 2.5% Stock Analytics
DIVIS LABORATORIES ₹165,359.0 Cr 1.8% 2.7% 17% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,431.0 Cr 0.5% -4.8% 32.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,114.0 Cr 0.3% -4.5% 11.5% Stock Analytics
CIPLA ₹100,028.0 Cr 0.7% -5.8% -13.1% Stock Analytics


JENBURKT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS

-2.5%

1.2%

0.9%

SENSEX

2.4%

3.2%

5.8%


You may also like the below Video Courses